This agenda is available for download in PDF format.* Click Here to download a PDF version of this page.
For information about downloading and viewing PDF files, or to download the free Adobe Acrobat software, Click Here or scroll to the bottom of this page.
|
|
| |
|
|
| Thursday, March 9, 2006 |
| |
|
|
| 7:55 a.m. - 8:00 a.m. |
Welcome |
Gary Curhan |
| |
|
|
| 8:00 a.m. - 10:00 a.m. |
Clinical Management Oral Session |
|
| |
|
|
| 8:00 a.m. - 9:00 a.m. |
Medical Management of Stone Disease |
|
| |
Moderator: David S. Goldfarb |
|
| |
 |
Future of trials in urolithiasis |
Leroy Nyberg Jr. and John Kusek |
 |
New medications for stone prevention |
John Asplin |
 |
Physiologic issues in the clinical management of calcium phosphate stones |
Mitch Halperin |
 |
Management of stones in the pediatric population |
Craig Langman |
 |
Long-term stone prevention: adherence and adverse effects of medications |
David Goldfarb |
 |
Pharmacogenomics and the Prevention of Stone Recurrence |
Carla Monico |
|
| |
|
|
| 9:00 a.m. - 10:00 a.m. |
Surgical Management of Stone Disease |
| |
Moderator: Martin Resnick |
|
| |
 |
Shokewave lithotripsy |
James Lingeman |
 |
Percutaneous nephrolithotomy |
Steven Nakada |
 |
Ureteroscopy |
John Denstedt |
 |
Laparoscopic approaches for renal and ureteral calculi |
Stuart Wolf |
|
| |
|
|
| 10:00 a.m. - 10:10 a.m. |
Comment Period for Clinical Management Session |
| |
|
|
| 10:10 a.m. - 10:30 a.m. |
Break |
|
| |
|
|
| 10:30 a.m. - 11:45 a.m. |
Imaging |
| |
Moderator: Dawn Milliner |
|
| |
 |
Preferred imaging modalities for stones |
Bruce McClennan |
 |
The future of stone imaging/New modalities to reduce radiation exposure |
Cynthia McCollough |
 |
Determination of stone composition and fragility by imaging |
James C. Williams, Jr. |
|
| |
|
|
| 11:45 a.m. - 11:55 a.m. |
Comment Period for Imaging Oral Session |
|
| |
|
|
| 12:00 noon - 1:00 p.m. |
Lunch |
|
| |
|
|
| 1:00 p.m. - 2:00 p.m. |
Critical Steps for Stone Formation |
| |
Moderator: Michael D. Ward |
|
| |
 |
Earliest phases of stone formation |
Fred Coe |
 |
Biomineralization of Uric Acid |
Jennifer Swift |
 |
Mechanisms of action of relevant urinary inhibitors |
Jeff A. Wesson |
 |
Cellular response to oxalate challenges |
Julie Jonassen |
|
| |
|
|
| 2:00 p.m. - 2:10 p.m. |
Comment Period for Stone Structure/Crystal Attachment Oral Session |
| |
|
|
| 2:10 p.m. - 3:40 p.m. |
Breakout Meetings * |
Moderator |
| |
 |
Clinical management |
Martin Resnick and David S. Goldfarb |
 |
Imaging |
Dawn Milliner |
 |
Critical steps for stone formation |
Michael Ward |
|
| |
|
|
| 3:40 p.m. - 4:00 p.m. |
Break |
| |
|
|
| 4:00 p.m. - 5:15 p.m. |
Pathophysiology |
| |
Moderator: Elaine Worcester |
|
| |
 |
Mechanisms of hypercalciuria |
Fred Coe |
 |
Uric acid and stone disease |
Khashayar Sakhaee |
 |
Obesity, bariatric surgery, and stone disease |
Elaine Worcester |
 |
Oxalate absorption and renal handling |
David Mount |
 |
Importance of citrate handling in stone disease |
Patricia Preisig |
|
| |
|
|
| 5:15 p.m. - 5:25 p.m. |
Comment Period for Pathophysiology |
| |
|
|
| 5:30 p.m. |
Adjourn |
| |
|
|
| |
|
|
| |
|
|
Back to Top |
|
| |
|
|
| |
|
|
| |
|
|
| Friday, March 10 |
| |
|
|
| 7:30 a.m. - 8:30 a.m. |
Animal Models |
| |
Moderator: John Lieske |
|
| |
 |
Models of hyperoxaluria: is any one preferred? |
Neil Mandel |
 |
What can models of hypercalciuria teach us about human nephrolithiasis? |
David Bushinsky |
 |
Other models of intrarenal crystal deposition |
Jay Tischfield |
 |
Newer genetic models of calcium stone disease |
Xue-Ru Wu |
|
| |
|
|
| 8:30 a.m. - 8:40 a.m. |
Comment Period |
| |
|
|
| 8:40 a.m. - 9:55 a.m. |
Genetics/Genomics/Proteomics Oral Session |
| |
Moderator: Orson Moe |
|
| |
 |
Can transcriptional profiling help with understanding kidney stones? |
Matthias Kretzler |
 |
Should NIDDK have a core facility and database for nephrolithiasis research? |
Erwin Bottinger |
 |
The potential role of urinary proteomics in nephrolithiasis |
John Arthur |
 |
Application of proteomics in renal tissue from patients with nephrolithiasis |
TBD |
|
| |
|
|
| 9:55 a.m. - 10:05 a.m. |
Comment Period for Genetics/Genomics/Proteomics Oral Session |
| |
|
|
| 10:05 a.m. - 11:50 a.m. |
Breakout Meetings * |
Moderator |
| |
 |
Pathophysiology |
Elaine Worcester |
 |
Animal Models |
John Lieske |
 |
Genetics/genomics/proteomis |
Orson Moe |
|
| |
|
|
| 11:50 a.m. - 12:50 p.m. |
Presentation of Major Recommendations by Each Breakout Group |
| |
|
|
| 1:00 p.m. |
Adjourn |
| |
|
|
| |
|
|
| |
|
|
|
| * The breakout sessions will not have posters or talks. The goal is to have a discussion about the issues that will be raised during the talks and by the breakout moderators. A written document will be prepared from each breakout session describing the recommendations for future research in the area. |